Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Leukemia, Myeloid, Accelerated Phase 1Leukemia 1Blast Crisis 1

Interventions

Cyclophosphamide 12Filgrastim 9fludarabine phosphate 8Etoposide 8Dasatinib 7Tacrolimus 6Peripheral Blood Stem Cell Transplantation 6Imatinib Mesylate 5Cytarabine 5sargramostim 4Cyclosporine 4Cord Blood Stem Cell Transplantation 4Carboplatin 4Antilymphocyte Serum 4tanespimycin 3Whole-Body Irradiation 3Vorinostat 3Sirolimus 3Prednisone 3Mycophenolic Acid 3Methylprednisolone 3Flow Cytometry 3Doxorubicin 3Busulfan 3tipifarnib 2Topotecan 2Thiotepa 2Sunitinib 2Specimen Handling 2Rituximab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Leukemia, Myeloid, Accelerated Phase × Cytogenetic Analysis × Clear all
NCT00816283 2012-07-17

Dasatinib and Vorinostat in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia

City of Hope Medical Center

Phase 1 Completed
5 enrolled
LymphoidOther hematologic neoplasm

Blast Crisis, Leukemia, Leukemia, Myeloid, Accelerated Phase, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡